• Salary and Benefits for Clinical Fellows

    AY 2021-22 Fellow Salaries:

        Annual Salary
      1st Year Clinical Fellow (Post-Graduate Year 4)   $80,785
      2nd Year Clinical Fellow (Post-Graduate Year 5)   $86,395
      3rd Year Clinical Fellow (Post-Graduate Year 6)   $93,050
      4th Year Clinical Fellow (Post-Graduate Year 7)   $95,870


    Benefits for Clinical Fellows:

    Salary and Benefits

    All fellows automatically receive:

    • Basic life insurance
    • Long-term disability
    • Employee Assistance Program (EAP)
    • Access to employee resource groups

    Fellows may elect to receive:

    • Health, dental, and vision insurance
    • Supplemental and dependent life insurance
    • A health savings account (HSA)
    • A flexible spending account (FSA)
    • Childcare resources including children’s daycare subsidy and emergency backup daycare
    • Pet insurance
    • English as a second language
    • Transportation assistance including MBTA pass programs, parking, commuter vanpool reimbursement
    • Adoption assistance
    • Fitness discounts and reimbursement
    • Home, auto, and renter’s insurance discounts
    • Headspace
    • 403(b) retirement plan

    Fellows also receive allowances to cover the following:

    • Subspecialty In-Training Examination (SITE) registration fees
    • Massachusetts medical license renewal
    • Drug Enforcement Administration (DEA) registration
    • Massachusetts Controlled Substances Registration
    • City of Boston registration fee
    • Pediatric Advanced Life Support (PALS) / Basic Life Support (BLS)
    • Boston Children’s Hospital meal card (in-house call)
  • Our Fellowship Programs

    The Pediatric Hematology/Oncology Fellowship Program at Dana-Farber/Boston Children's is one of the most recognized in the nation with a long history of training leaders in the field. 
  • Top Ranked for Cancer Care

    U.S. News Best Children's Hospitals logoWorld class cancer care at the #1 children's hospital

  • A Long Legacy of Research and Treatment

    Dana-Farber/Boston Children's History

    More than 70 years ago, Dr. Sidney Farber refused to accept that childhood cancer was untreatable. His determination led to the development of chemotherapy and the first remissions of childhood leukemia.